WHO ICTRP trial
Neuropathologic and Neurochemical Imaging Technologies and Their Clinical…
KCT0000379 · Clinical Research Information Service (CRIS) · Recruiting
Key facts
| Trial ID | KCT0000379 |
|---|---|
| Public title | Neuropathologic and Neurochemical Imaging Technologies and Their Clinical Applications in Alzheimer's Disease |
| Scientific title | Phase 1 and Phase 2 clinical trials for the evaluation of pharmacokinetics, safety, and efficacy of SNUBH-NM-333(18F), a new diagnostic radiopharmaceutical for PET imaging of amyloid plaques, in Alzheimer's disease patients and healthy volunteers |
| Primary sponsor | Seoul National University Bundang Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Recruiting |
| Study type | Interventional Study |
| Phase | Phase1/Phase2 |
| Countries | Korea, Republic of |
| Conditions | Mental and behavioral disorders |
| Interventions | Radiation : radiopharmaceutical: SNUBH-NM-333(18F) volume: 5~10CC number: 1 period: once injection route: intra vein subject: Alzheimer's disease patients, healthy volunteers |
| Registration date | Mar 12, 2012 |
| Target size | 30 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: